
Rituximab versus tocilizumab and B-cell status in TNF-alpha inadequate-responder rheumatoid arthritis patients: the R4-RA RCT
Author(s) -
Frances Humby,
Patrick Durez,
Maya H Buch,
Myles Lewis,
Michèle Bombardieri,
Christopher R. John,
Hasan Rizvi,
Louise Warren,
Joanna Peel,
Liliane Fossati-Jimack,
Rebecca Hands,
Giovanni Giorli,
Felice Rivellese,
Juan D. Cañete,
Peter C Taylor,
Peter Sasieni,
João Eurico Fonseca,
Ernest Choy,
Costantino Pitzalis
Publication year - 2022
Publication title -
efficacy and mechanism evaluation
Language(s) - English
Resource type - Journals
eISSN - 2050-4373
pISSN - 2050-4365
DOI - 10.3310/gopl1729
Subject(s) - medicine , rituximab , tocilizumab , rheumatoid arthritis , cd20 , rheumatology , immunology , gastroenterology , lymphoma